Results 321 to 330 of about 928,606 (352)

Platinum Drug Distribution in Cancer Cells and Tumors

Chemical Reviews, 2009
Trevor W Hambley
exaly  

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

Lancet, The, 2018
Thomas Powles, Ignacio Duran, Michiel S Van Der Heijden   +2 more
exaly  

Virilizing Hepatoblastoma: Precocious Sexual Development and Partial Response of Pulmonary Metastases to Cis-Platinum

Ca-A Cancer Journal for Clinicians, 1982
exaly  

First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

Lancet, The, 2017
Jean-Charles Soria, Alexis B Cortot, Rita Chiari   +2 more
exaly  

PLATINUM

2011
  +4 more sources

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2016
Jonathan A Ledermann, Andrew C Embleton, Timothy J Perren   +2 more
exaly  

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

Lancet, The, 2003
exaly  

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

Lancet, The, 2016
Jean Hoffman-Censits, Michiel S Van Der Heijden, Andrea Necchi   +2 more
exaly  

Ordered nanoporous arrays of carbon supporting high dispersions of platinum nanoparticles

Nature, 2001
S. Joo, Seong Jae Choi, Ilwhan Oh, Juhyoun Kwak, Zheng Liu, O. Terasaki, R. Ryoo   +6 more
semanticscholar   +1 more source

Current Status of Platinum-Based Antitumor Drugs

Chemical Reviews, 1999
exaly